These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36634)

  • 21. The effect of somatostatin and of prolyl-leucyl-glycinamide (MIF) on ACTH release in dispersed pituitary cells.
    Voight KH; Fehm HL; Lang RE; Walter R
    Life Sci; 1977 Sep; 21(5):739-45. PubMed ID: 20545
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
    Hatta K; Wolterink G; Van Ree JM
    Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference.
    Pulvirenti L; Kastin AJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):129-34. PubMed ID: 2908062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice.
    Teskey GC; Kavaliers M
    Peptides; 1985; 6(2):165-7. PubMed ID: 2863808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin does not mediate the inhibition of ethanol drinking by the renin-angiotensin system.
    Ross AD; Perlanski E; Grupp LA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):761-5. PubMed ID: 2217503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.
    Kostrzewa RM; Kastin AJ; Sobrian SK
    Pharmacol Biochem Behav; 1978 Sep; 9(3):375-8. PubMed ID: 30981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of toluene on ethanol preference in rats.
    Ladefoged O; Kjaer V; Larsen JJ
    Pharmacol Toxicol; 1990 Oct; 67(4):302-6. PubMed ID: 2077521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
    Rajakumar G; Singh AN; Naas F; Chiu S; Kwan CY; Johnson RL; Mishra RK
    J Hypertens Suppl; 1986 Dec; 4(5):S106-8. PubMed ID: 2883271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine-vasopressin and lysine-vasopressin have different effects on spontaneous behaviour of rats.
    Tendis S; Klingberg F; Schaeker W
    Biomed Biochim Acta; 1987; 46(10):719-25. PubMed ID: 3446200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethanol preference in homozygous diabetes insipidus (Brattleboro) rats: effect of vasopressin fragments.
    Rigter H; Crabbe J
    Ann N Y Acad Sci; 1982; 394():663-71. PubMed ID: 6960789
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat.
    Dickinson SL; Slater P; Longman DA
    Neuropharmacology; 1981 Aug; 20(8):757-62. PubMed ID: 6116207
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease.
    Case TC; Snider SR; Hruby VJ; Rockway T
    Life Sci; 1985 Jul; 36(26):2531-7. PubMed ID: 2861549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemically administered prolyl-leucyl-glycinamide fails to alter dopaminergic neuronal activity in the rat brain.
    Alper RH; Moore KE
    J Pharm Pharmacol; 1981 Apr; 33(4):259-61. PubMed ID: 6115917
    [No Abstract]   [Full Text] [Related]  

  • 39. Memory enhancement induced in chicks by L-prolyl-L-leucyl-glycinamide.
    Davis JL; Pico RM; Cherkin A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):893-6. PubMed ID: 6129646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced ethanol consumption during cyproheptadine administration in rats from a long-term alcohol-treated colony.
    Esteban MM; Fueyo A; Rojo-Ortega JM; Marin B
    Physiol Behav; 1986; 38(2):247-54. PubMed ID: 3797491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.